EIM
PGNX

Essex Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Essex Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,851
Closed -$160K – 449
2018
Q2 		$160K Buy
+19,851
New +$160K 0.02% 386